RESUMEN
OBJECTIVE: An audit of opioid prescribing in a large teaching hospital across all specialties was conducted to identify areas for improvement. METHODS: Opioid medications prescribed for the entire patient admission were recorded and assessed using quality statements. RESULTS AND DISCUSSION: Of 334 patients reviewed 209 (62.6%) were prescribed an opioid. Poly-prescribing of 'when required' (p.r.n.) opioids was frequent with 107 (51.2%) patients having more than one 'p.r.n.' opioid. Dosing intervals were too long for 146 (69.8%) patients leaving them at risk of breakthrough pain. The intramuscular route was prescribed for 100 (47.8%) patients, and 49 (23.4%) of prescriptions had an inappropriate variety of administration routes. CONCLUSION: Although the criteria for assessing opioid prescribing were stringent the prescribing was sub-optimal. This survey will form the basis for future quality initiatives.
Asunto(s)
Analgésicos Opioides/uso terapéutico , Prescripciones de Medicamentos , Revisión de la Utilización de Medicamentos , Dolor/tratamiento farmacológico , Analgésicos Opioides/administración & dosificación , Hospitales de Enseñanza , Humanos , Pacientes Internos , Indicadores de Calidad de la Atención de Salud , Australia OccidentalRESUMEN
BACKGROUND: Most clinical symptoms of Huntington disease (HD) have been attributed to striatal degeneration, but extrastriatal degeneration may play an important role in the clinical symptoms because postmortem studies demonstrate that almost all brain structures atrophy. OBJECTIVE: To fully characterize the morphometric changes that occur in vivo in HD. METHODS: High-resolution 1.5 mm T1-weighted coronal scans were acquired from 18 individuals in early to mid-stages of HD and 18 healthy age-matched controls. Cortical and subcortical gray and white matter were segmented using a semiautomated intensity contour-mapping algorithm. General linear models for correlated data of the volumes of brain regions were used to compare groups, controlling for age, education, handedness, sex, and total brain volumes. RESULTS: Subjects with HD had significant volume reductions in almost all brain structures, including total cerebrum, total white matter, cerebral cortex, caudate, putamen, globus pallidus, amygdala, hippocampus, brainstem, and cerebellum. CONCLUSIONS: Widespread degeneration occurs in early to mid-stages of HD, may explain some of the clinical heterogeneity, and may impact future clinical trials.
Asunto(s)
Encéfalo/patología , Enfermedad de Huntington/patología , Imagen por Resonancia Magnética , Adulto , Atrofia , Estudios de Casos y Controles , Femenino , Humanos , Masculino , Persona de Mediana Edad , Degeneración Nerviosa , Factores de TiempoRESUMEN
BACKGROUND: Huntington's disease (HD) is a fatal and progressive neurodegenerative disease that is accompanied by involuntary movements, cognitive dysfunction, and psychiatric symptoms. Although progressive striatal degeneration is known to occur, little is known about how the disease affects the cortex, including which cortical regions are affected, how degeneration proceeds, and the relationship of the cortical degeneration to clinical symptoms. The cortex has been difficult to study in neurodegenerative diseases primarily because of its complex folding patterns and regional variability; however, an understanding of how the cortex is affected by the disease may provide important new insights into it. METHODS: Novel automated surface reconstruction and high-resolution MR images of 11 patients with HD and 13 age-matched subjects were used to obtain cortical thickness measurements. The same analyses were performed on two postmortem brains to validate these methods. RESULTS: Regionally specific heterogeneous thinning of the cortical ribbon was found in subjects with HD. Thinning occurred early, differed among patients in different clinical stages of disease, and appeared to proceed from posterior to anterior cortical regions with disease progression. The sensorimotor region was statistically most affected. Measurements performed on MR images of autopsy brains analyzed similarly were within 0.25 mm of those obtained using traditional neuropathologic methods and were statistically indistinguishable. CONCLUSIONS: The authors propose that the cortex degenerates early in disease and that regionally selective cortical degeneration may explain the heterogeneity of clinical expression in HD. These measures might provide a sensitive prospective surrogate marker for clinical trials of neuroprotective medications.
Asunto(s)
Corteza Cerebral/patología , Enfermedad de Huntington/patología , Imagen por Resonancia Magnética/métodos , Adulto , Femenino , Humanos , Enfermedad de Huntington/fisiopatología , Masculino , Persona de Mediana EdadRESUMEN
The use of functional magnetic resonance imaging (fMRI) techniques for evaluation of pharmacologic stimuli has great potential for understanding neurotransmitter dynamics for a number of brain disorders, such as drug abuse, schizophrenia, epilepsy, or neurodegeneration. Unfortunately, blood oxygenation level-dependent (BOLD) imaging at common fields strengths, such as 1.5 or 3 T, has very low sensitivity and contrast-to-noise ratios (CNRs). We demonstrate here the utility of using an intravascular superparamagnetic iron oxide contrast agent with a long plasma half-life for evaluation of hemodynamic changes related to dopaminergic stimuli using amphetamine or the cocaine analog 2beta-carbomethoxy-3beta-(4-fluorophenyl)tropane (CFT). We refer to this technique as increased relaxation with iron oxide nanoparticles (IRON). Results obtained here show that even at field strengths as high as 4.7 T, one can obtain increases in CNR by factors of 2-3 over BOLD imaging that lead to greater than an order of magnitude increase in statistical power with greatly increased sensitivity to hemodynamic changes in brain regions difficult to observe using BOLD imaging. Furthermore, use of the intravascular contrast agent allows for a meaningful physiologic parameter to be measured (relative cerebral blood volume (rCBV)), compared to conventional BOLD imaging.
Asunto(s)
Encéfalo/anatomía & histología , Compuestos Férricos , Imagen por Resonancia Magnética/métodos , Animales , Encéfalo/efectos de los fármacos , Encéfalo/fisiología , Medios de Contraste , Ratas , Ratas Sprague-DawleyRESUMEN
BACKGROUND: Huntington's disease (HD) is an autosomal dominant neurodegenerative disease that results from the expansion of a trinucleotide (CAG) repeat on chromosome 4. Progressive degeneration of the striatum is the pathologic hallmark of the disease. Little is known about the regional selectivity of the neurodegeneration and its relationship to the genetic expansion. METHODS: The authors used high-resolution MRI to determine the relationship between the genetic expansion and the degree of striatal degeneration. Morphometric analyses of the striatum from high-resolution MR images from 27 subjects with HD were compared with those of 24 healthy control subjects. RESULTS AND CONCLUSIONS: Striatal volumes were reduced in subjects with HD as compared with control subjects, in agreement with previously published reports. Left-sided volumes were smaller than right-sided volumes in subjects with HD; in healthy subjects, right-sided volumes were smaller. Finally, volume loss was significantly correlated with CAG repeat number. These results have potential implications for the design and assessment of therapeutic agents in the future.
Asunto(s)
Cromosomas Humanos Par 4 , Cuerpo Estriado/patología , Enfermedad de Huntington/genética , Imagen por Resonancia Magnética , Repeticiones de Trinucleótidos , Adulto , Progresión de la Enfermedad , Femenino , Estudios de Seguimiento , Humanos , Enfermedad de Huntington/diagnóstico , Masculino , Persona de Mediana Edad , Degeneración Nerviosa/genética , Degeneración Nerviosa/patologíaRESUMEN
There is substantial evidence for bioenergetic defects in Huntington's disease (HD). Creatine administration increases brain phosphocreatine levels and it stabilizes the mitochondrial permeability transition. We examined the effects of creatine administration in a transgenic mouse model of HD produced by 82 polyglutamine repeats in a 171 amino acid N-terminal fragment of huntingtin (N171-82Q). Dietary supplementation of 2% creatine significantly improved survival, slowed the development of motor symptoms, and delayed the onset of weight loss. Creatine lessened brain atrophy and the formation of intranuclear inclusions, attenuated reductions in striatal N-acetylaspartate as assessed by NMR spectroscopy, and delayed the development of hyperglycemia. These results are similar to those observed using dietary creatine supplementation in the R6/2 transgenic mouse model of HD and provide further evidence that creatine may exert therapeutic effects in HD.
Asunto(s)
Creatinina/farmacología , Enfermedad de Huntington/tratamiento farmacológico , Enfermedad de Huntington/metabolismo , Actividad Motora/efectos de los fármacos , Neuronas/patología , Animales , Ácido Aspártico/análogos & derivados , Ácido Aspártico/metabolismo , Glucemia , Química Encefálica/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Modelos Animales de Enfermedad , Metabolismo Energético/efectos de los fármacos , Metabolismo Energético/fisiología , Femenino , Proteína Huntingtina , Enfermedad de Huntington/mortalidad , Hiperglucemia/metabolismo , Insulina/sangre , Espectroscopía de Resonancia Magnética , Masculino , Ratones , Ratones Transgénicos , Neostriado/efectos de los fármacos , Neostriado/patología , Proteínas del Tejido Nervioso/genética , Neuronas/efectos de los fármacos , Proteínas Nucleares/genética , Tamaño de los Órganos , Tasa de SupervivenciaRESUMEN
Several lines of evidence implicate excitotoxic mechanisms in the pathogenesis of amyotrophic lateral sclerosis (ALS). Transgenic mice with a superoxide dismutase mutation (G93A) have been utilized as an animal model of familial ALS (FALS). We examined the cortical concentrations of glutamate using in vivo microdialysis and in vivo nuclear magnetic resonance (NMR) spectroscopy, and the effect of long-term creatine supplementation. NMDA-stimulated and Ltrans-pyrrolidine-2,4-dicarboxylate (LTPD)-induced increases in glutamate were significantly higher in G93A mice compared with littermate wild-type mice at 115 days of age. At this age, the tissue concentrations of glutamate were also significantly increased as measured with NMR spectroscopy. Creatine significantly increased longevity and motor performance of the G93A mice, and significantly attenuated the increases in glutamate measured with spectroscopy at 75 days of age, but had no effect at 115 days of age. These results are consistent with impaired glutamate transport in G93A transgenic mice. The beneficial effect of creatine may be partially mediated by improved function of the glutamate transporter, which has a high demand for energy and is susceptible to oxidative stress.
Asunto(s)
Química Encefálica/efectos de los fármacos , Creatina/uso terapéutico , Ácido Glutámico/metabolismo , Enfermedad de la Neurona Motora/tratamiento farmacológico , Transportadoras de Casetes de Unión a ATP/metabolismo , Sistema de Transporte de Aminoácidos X-AG , Animales , Transporte Biológico/efectos de los fármacos , Peso Corporal/efectos de los fármacos , Creatina/farmacología , Ácidos Dicarboxílicos/farmacología , Ácidos Dicarboxílicos/toxicidad , Modelos Animales de Enfermedad , Agonistas de Aminoácidos Excitadores/farmacología , Agonistas de Aminoácidos Excitadores/toxicidad , Glutamina/metabolismo , Espectroscopía de Resonancia Magnética , Masculino , Ratones , Ratones Transgénicos , Microdiálisis , Actividad Motora/efectos de los fármacos , Enfermedad de la Neurona Motora/genética , Enfermedad de la Neurona Motora/metabolismo , N-Metilaspartato/farmacología , N-Metilaspartato/toxicidad , Inhibidores de la Captación de Neurotransmisores/farmacología , Inhibidores de la Captación de Neurotransmisores/toxicidad , Estrés Oxidativo , Desempeño Psicomotor/efectos de los fármacos , Pirrolidinas/farmacología , Pirrolidinas/toxicidad , Superóxido Dismutasa/deficiencia , Superóxido Dismutasa/genéticaRESUMEN
Functional MRI of rat brain was performed at 2 Tesla following intravenous injection of cocaine in order to 1) determine if changes in CBV and changes in BOLD signal were regionally coupled in brain parenchyma, and 2) compare the sensitivities of these imaging methods across different brain structures. Percent changes in CBV and BOLD relaxation rate were spatially and temporally coupled during this graded brain activation. The use of contrast agent increased functional sensitivity in all parenchymal brain structures, with a strong but predictable dependence on the resting-state blood volume fraction. Magn Reson Med 45:443-447, 2001.
Asunto(s)
Encéfalo/irrigación sanguínea , Cocaína/farmacología , Aumento de la Imagen , Imagen por Resonancia Magnética/métodos , Animales , Velocidad del Flujo Sanguíneo/efectos de los fármacos , Velocidad del Flujo Sanguíneo/fisiología , Volumen Sanguíneo/efectos de los fármacos , Volumen Sanguíneo/fisiología , Encéfalo/patología , Mapeo Encefálico , Medios de Contraste , Óxido Ferrosoférrico , Interpretación de Imagen Asistida por Computador , Hierro , Masculino , Óxidos , Ratas , Ratas Sprague-Dawley , Valores de Referencia , Flujo Sanguíneo Regional/efectos de los fármacos , Flujo Sanguíneo Regional/fisiologíaRESUMEN
Although perfusion-weighted imaging techniques are increasingly used to study stroke, no particular hemodynamic variable has emerged as a standard marker for accumulated ischemic damage. To better characterize the hemodynamic signature of infarction. the authors have assessed the severity and temporal evolution of ischemic hemodynamics in a middle cerebral artery occlusion model in the rat. Cerebral blood flow (CBF) and total and microvascular cerebral blood volume (CBV) changes were measured with arterial spin labeling and steady-state susceptibility contrast magnetic resonance imaging (MRI), respectively, and analyzed in regions corresponding to infarcted and spared ipsilateral tissue, based on 2,3,5-triphenyltetrazolium chloride histology sections after 24 hours ischemia. Spin echo susceptibility contrast was used to measure microvascular-weighted CBV, which had a maximum sensitivity for vessels with radii between 4 and 30 microm. Serial measurements between 1 and 3 hours after occlusion showed no change in CBF (22 +/- 20% of contralateral, mean +/- SD) or in total CBV (78 +/- 13% of contralateral) in regions destined to infarct. However, microvascular CBV progressively declined from 72 +/- 5% to 64 +/- 11% (P < 0.01) during this same period. Microvascular CBV changes with time were entirely due to decreases in subcortical infarcted zones (from 73 +/- 9% to 57 +/- 14%. P < 0.001) without changes in the cortical infarcted territory. The hemodynamic variables showed differences in magnitude and temporal response, and these changes varied based on histologic outcome and brain architecture. Such factors should be considered when designing imaging studies for human stroke.
Asunto(s)
Isquemia Encefálica/diagnóstico por imagen , Infarto Cerebral/diagnóstico por imagen , Circulación Cerebrovascular , Imagen por Resonancia Magnética/métodos , Animales , Isquemia Encefálica/fisiopatología , Infarto Cerebral/fisiopatología , Humanos , Masculino , Radiografía , Ratas , Ratas Sprague-Dawley , Sensibilidad y EspecificidadRESUMEN
We investigated the basal ganglia, motor cortex area 4, and supplementary motor area (SMA) using functional magnetic resonance imaging (fMRI) and five motor tasks: switching between finger and toe movements, writing, finger tapping, pronation/supination, and saccadic eye movements. We found reliable activation in the caudate nucleus and putamen in single subjects without the need for inter-subject averaging. Percent signal changes in basal ganglia were smaller by a factor of three than those in SMA or motor cortex (1% vs. 2.5-3%). There was a definite foot-dorsal, hand-ventral basal ganglia somatotopy, similar to prior data from primates. Saccadic eye movements activated the caudate nucleus significantly more than the other tasks did. Unilateral movements produced bilateral activation in the striatum even when motor cortex activation was unilateral. Surprisingly, bilateral performance of the tasks led, on average, to consistently smaller basal ganglia activation than did unilateral performance (P<0.001), suggesting less inhibition of contralateral movements during bilateral tasks. Moreover, there was a striking dominance pattern in basal ganglia motor activation: the left basal ganglia were more active than the right for right handers, regardless of the hand used. This lateralization appears much stronger than that previously reported for motor cortex. Comparisons of inter-subject and intra-subject reproducibility indicated a much larger variability in basal ganglia and SMA compared to motor cortex, in spite of similar percent signal changes in the latter two structures.
Asunto(s)
Ganglios Basales/fisiología , Mapeo Encefálico/métodos , Actividad Motora/fisiología , Corteza Motora/fisiología , Desempeño Psicomotor/fisiología , Tálamo/fisiología , Adulto , Femenino , Dedos/inervación , Lateralidad Funcional , Mano/inervación , Humanos , Imagen por Resonancia Magnética/métodos , Masculino , Persona de Mediana Edad , Reproducibilidad de los Resultados , Movimientos Sacádicos , Dedos del Pie/inervaciónRESUMEN
Huntington's disease (HD) is a progressive neurodegenerative illness for which there is no effective therapy. We examined whether creatine, which may exert neuroprotective effects by increasing phosphocreatine levels or by stabilizing the mitochondrial permeability transition, has beneficial effects in a transgenic mouse model of HD (line 6/2). Dietary creatine supplementation significantly improved survival, slowed the development of brain atrophy, and delayed atrophy of striatal neurons and the formation of huntingtin-positive aggregates in R6/2 mice. Body weight and motor performance on the rotarod test were significantly improved in creatine-supplemented R6/2 mice, whereas the onset of diabetes was markedly delayed. Nuclear magnetic resonance spectroscopy showed that creatine supplementation significantly increased brain creatine concentrations and delayed decreases in N-acetylaspartate concentrations. These results support a role of metabolic dysfunction in a transgenic mouse model of HD and suggest a novel therapeutic strategy to slow the pathological process.
Asunto(s)
Creatina/uso terapéutico , Enfermedad de Huntington/tratamiento farmacológico , Proteínas del Tejido Nervioso/genética , Neuronas/patología , Fármacos Neuroprotectores/uso terapéutico , Proteínas Nucleares/genética , Animales , Animales Modificados Genéticamente , Ácido Aspártico/análogos & derivados , Ácido Aspártico/metabolismo , Atrofia , Encéfalo/efectos de los fármacos , Encéfalo/patología , Cuerpo Estriado/efectos de los fármacos , Cuerpo Estriado/patología , Creatina/administración & dosificación , Creatina/metabolismo , Cruzamientos Genéticos , Suplementos Dietéticos , Femenino , Humanos , Proteína Huntingtina , Enfermedad de Huntington/patología , Enfermedad de Huntington/fisiopatología , Imagen por Resonancia Magnética , Masculino , Ratones , Ratones Endogámicos , Actividad Motora/efectos de los fármacos , Neuronas/efectos de los fármacos , Fármacos Neuroprotectores/administración & dosificaciónRESUMEN
Mice transgenic for exon I of mutant huntingtin, with 141 CAG repeats, exhibit a profound symptomatology characterized by weight loss, motor disorders, and early death. We performed longitudinal analysis of metabolite levels in these mice using NMR spectroscopy in vivo and in vitro. These mice exhibited a large (53%), nonlinear drop in in vivo N-acetyl aspartate (NAA) levels over time, commencing at approximately 6 weeks of age, coincident with onset of symptoms. These drops in NAA levels occurred in the absence of neuronal death as measured by postmortem Nissl staining and neuronal counting but in the presence of nuclear inclusion bodies. In addition to decreased NAA, these mice showed a large elevation of glucose in the brain (600%) consistent with a diabetic profile and elevations in blood glucose levels both before and after glucose loading. In vitro NMR analysis revealed significant increases in glutamine (100%), taurine (95%) cholines (200%), and scyllo-inositol (333%) and decreases in glutamate (24%) and succinate (47%). These results lead to two conclusions. NAA is reflective of the health of neurons and thus is a noninvasive marker, with a temporal progression similar to nuclear inclusion bodies and symptoms, of neuronal dysfunction in transgenic mice. Second, the presence of elevated glutamine is evidence of a profound metabolic defect. We present arguments that the elevated glutamine results from a decrease in neuronal-glial glutamate-glutamine cycling and a decrease in glutaminase activity.
Asunto(s)
Ácido Aspártico/análogos & derivados , Glucosa/metabolismo , Glutamina/metabolismo , Enfermedad de Huntington/metabolismo , Enfermedad de Huntington/patología , Neuronas/patología , Animales , Ácido Aspártico/metabolismo , Glucemia/análisis , Encéfalo/metabolismo , Humanos , Enfermedad de Huntington/diagnóstico , Enfermedad de Huntington/genética , Espectroscopía de Resonancia Magnética , Ratones , Ratones Transgénicos/genética , Ratones Transgénicos/metabolismo , Dinámicas no Lineales , Factores de TiempoRESUMEN
Receptor supersensitivity is an important concept for understanding neurotransmitter and receptor dynamics. Traditionally, detection of receptor supersensitivity has been performed using autoradiography or positron emission tomography (PET). We show that use of magnetic resonance imaging (MRI) not only enables one to detect dopaminergic supersensitivity, but that the hemodynamic time course reflective of this fact is different in different brain regions. In rats unilaterally lesioned with intranigral 6-hydroxydopamine, apomorphine injections lead to a large increase in hemodynamic response (cerebral blood volume, CBV) in the striato-thalamo-cortico circuit on the lesioned side but had little effect on the intact side. Amphetamine injections lead to increases in hemodynamic responses on the intact side and little on the lesioned side in the same animals. The time course for the increase in CBV after either amphetamine or apomorphine administration was longer in striatum and thalamus than in frontal cortex. (11)C-PET studies of ligands which bind to the dopamine transporter (2-beta-carbomethoxy-3-beta-(4-fluorophenyl)tropane 1, 5-naphthalnendisulfonate, WIN 35, 428 or CFT) and D2 receptors (raclopride) confirm that there is a loss of presynaptic dopamine terminals as well as upregulation of D2 receptors in striatum in these same animals. Pharmacologic MRI should become a sensitive tool to measure functional supersensitivity in humans, providing a complementary picture to that generated using PET studies of direct receptor binding.
Asunto(s)
Receptores Dopaminérgicos/efectos de los fármacos , Anfetamina/farmacología , Animales , Apomorfina/farmacología , Circulación Cerebrovascular/efectos de los fármacos , Cocaína/análogos & derivados , Cocaína/farmacología , Agonistas de Dopamina/farmacología , Inhibidores de Captación de Dopamina/farmacología , Hemodinámica/efectos de los fármacos , Imagen por Resonancia Magnética , Masculino , Neostriado/anatomía & histología , Neostriado/irrigación sanguínea , Neostriado/metabolismo , Oxidopamina , Ratas , Ratas Sprague-Dawley , Receptores de Dopamina D2/efectos de los fármacos , Rotación , Conducta Estereotipada/efectos de los fármacos , Simpatectomía Química , Simpaticolíticos , Tomografía Computarizada de EmisiónRESUMEN
We demonstrate the use of magnetic resonance imaging (MRI) for detection of neurotransmitter stimulation using the dopamine transporter ligands amphetamine and CFT (2beta-carbomethoxy-3beta-(4-fluorophenyl)tropane) as pharmacological challenges. We demonstrate that the unilateral loss of a hemodynamic response to either amphetamine or CFT challenge by unilateral 6-hydroxydopamine lesioning is restored by transplantation of fetal dopamine neurons in the striatum. The time course for the hemodynamic changes parallels the time courses for dopamine release, measured by prior microdialysis studies, and also for the rotational behavior in the unilaterally lesioned animals. Transplantation of the fetal cells results in hemodynamic time courses after CFT or amphetamine challenges at the graft site that are identical to those induced both before transplantation and on the intact contralateral side. The transplantation also results in complete behavioral recovery. The spatial extent of the dopaminergic recovery in the lesioned striatum is the same when measured using either PET of tracer levels of [11C]CFT binding or MRI. These results show great promise for the application of pharmacological MRI for application to studies of dopamine cell loss and potential recovery in Parkinson's disease.
Asunto(s)
Conducta Animal/fisiología , Trasplante de Células/fisiología , Dopamina/fisiología , Neuronas/fisiología , Anfetamina , Animales , Cocaína/análogos & derivados , Inhibidores de Captación de Dopamina , Femenino , Imagen por Resonancia Magnética , Microdiálisis , Ratas , Ratas Sprague-Dawley , Degeneración Estriatonigral , Simpatectomía Química , Tomografía Computarizada de EmisiónRESUMEN
PURPOSE: To study metabolic and hemodynamic correlates of photic stimulation-triggered discharges. METHODS: Simultaneous EEG, functional MRI (tMRI) and magnetic resonance spectroscopy (MRS) were performed in nine patients with photosensitive epilepsy and in 12 normal subjects. RESULTS: Prominent visual cortex activation was seen in all normal subjects and patients, and no tMRI-registered hemodynamic abnormalities were correlated with the brief photoparoxysmal spike-wave activity evoked in the photosensitive patients. However, irrespective of the presence of a spike-wave response to the photic stimulation, the photosensitive patients showed four findings not seen in the normal subjects: (a) slightly, but significantly, elevated lactate levels in the occipital cortex in the resting state; (b) an increased area of visual cortical activation with photic stimulation; (c) simultaneous with the occipital cortex stimulus-induced increased fMRI signal, there were noncontiguous areas of signal attenuation most prominent in perirolandic regions; and (d) a marked decrement (undershoot) of fMRI signal intensity immediately after the photic stimulation in the occipital cortex and in the region of the posterior cingulate gyrus. CONCLUSIONS: These findings suggest abnormal interictal metabolism and increased vascular reactivity in the photosensitive patients.
Asunto(s)
Epilepsia/diagnóstico , Imagen por Resonancia Magnética , Espectroscopía de Resonancia Magnética , Estimulación Luminosa , Adolescente , Adulto , Corteza Cerebral/irrigación sanguínea , Corteza Cerebral/fisiología , Circulación Cerebrovascular , Electroencefalografía/estadística & datos numéricos , Epilepsia/etiología , Epilepsia/metabolismo , Femenino , Giro del Cíngulo/metabolismo , Giro del Cíngulo/fisiología , Humanos , Hidrógeno , Lactatos/análisis , Masculino , Persona de Mediana Edad , Lóbulo Occipital/química , Estimulación Luminosa/métodos , Flujo Sanguíneo Regional , Corteza Visual/irrigación sanguínea , Corteza Visual/metabolismo , Corteza Visual/fisiologíaRESUMEN
PURPOSE: To study in humans the hemodynamic and metabolic consequences of both photic stimulation-triggered and spontaneous generalized epileptiform discharges. METHODS: Simultaneous EEG, functional magnetic resonance imaging (fMRI) and MR spectroscopy were performed in a 1.5-T scanner in 16 patients with generalized epilepsy, including nine with photosensitive epilepsy, and 12 normal subjects. RESULTS: With a flash stimulation duration of 2 s, prominent visual cortex activation was seen in all normals and patients. There were no fMRI-registered hemodynamic abnormalities found in relation to the brief photoparoxysmal spike-wave activity evoked in the photosensitive patients. However, irrespective of the presence of a spike-wave response to the photic stimulation, the photosensitive patients showed four unique findings compared with normals: (a) slightly, but significantly, increased lactate levels in the occipital cortex in the resting state, (b) an increased area of visual cortical activation with photic stimulation, (c) simultaneous with the occipital cortex stimulus-induced increased fMRI signal there were noncontiguous areas of signal attenuation most prominent in perirolandic regions, and (d) a marked decrement (undershoot) of fMRI signal intensity immediately after the photic stimulation in the occipital cortex and in the region of the posterior cingulate gyrus. CONCLUSIONS: These findings suggest abnormal interictal metabolism and increased vascular reactivity in the photosensitive patients.
Asunto(s)
Corteza Cerebral/irrigación sanguínea , Corteza Cerebral/metabolismo , Epilepsia/diagnóstico , Luz/efectos adversos , Imagen por Resonancia Magnética , Espectroscopía de Resonancia Magnética , Adolescente , Adulto , Corteza Cerebral/fisiopatología , Electroencefalografía , Epilepsia/metabolismo , Epilepsia/fisiopatología , Epilepsia Generalizada/diagnóstico , Epilepsia Generalizada/metabolismo , Epilepsia Generalizada/fisiopatología , Femenino , Hemodinámica/fisiología , Humanos , Lactatos/metabolismo , Masculino , Persona de Mediana Edad , Estimulación Luminosa , Corteza Visual/irrigación sanguínea , Corteza Visual/metabolismo , Corteza Visual/fisiopatologíaRESUMEN
We conducted PET imaging studies of modulation of dopamine transporter function and MRS studies of neurochemicals in idiopathic primate Parkinson's disease (PD) model induced by long-term, low-dose administration of MPTP. MR spectra showed striking similarities of the control spectrum of the primate and human striatum as well as MPTP-treated primate (six months after cessation of MPTP), and Parkinson's disease patient striatum (68 year old male; Hoehn-Yahr scale II; 510 mg/d L-DOPA). The choline/creatine ratio was similar in the MPTP model and human parkinsonism, suggesting a possible glial abnormality. The progressive degeneration of dopamine re-uptake sites observed in our PD model can be expressed by a time dependent exponential equation N(t) = N0 exp (-(0.072 +/- 0.016) t), where N0 represents intact entities (dopamine re-uptake sites before MPTP) and 0.072 per month is the rate of degeneration. When the signs of PD appear, N(t) is about 0.3-0.4 times N0. Interestingly, this biological degenerative phenomena has similar progression to that observed in cell survival theory. According to this theory and calculated degeneration rate, predictive models can be produced for regeneration and protective treatments.
Asunto(s)
Dopamina/análisis , Enfermedad de Parkinson/metabolismo , Corteza Visual/química , 1-Metil-4-fenil-1,2,3,6-Tetrahidropiridina , Anciano , Animales , Biomarcadores/análisis , Cocaína/análogos & derivados , Cocaína/metabolismo , Modelos Animales de Enfermedad , Inhibidores de Captación de Dopamina/metabolismo , Haplorrinos , Humanos , Macaca fascicularis , Imagen por Resonancia Magnética , Masculino , Modelos Biológicos , Enfermedad de Parkinson/patología , Tomografía Computarizada de Emisión/métodos , Corteza Visual/efectos de los fármacos , Corteza Visual/metabolismoRESUMEN
A novel method of chemical shift imaging utilizing echoplanar imaging (EPI) has been developed for the purpose of improving the spatial resolution of metabolite images for the specific goal of high spatial resolution mapping of neuronal content. An EPI sequence was modified to allow temporal offsets of the 180 degree refocusing pulse that encode the chemical shift information into the phase of the signal. Implementation of this method on 1.5 and 3 T human imagers has resulted in images of N-acetyl aspartate in humans with spatial resolution of 360 microl and signal-to-noise ratio approximately 7:1 in less than 13 min.
Asunto(s)
Encéfalo/metabolismo , Imagen Eco-Planar/métodos , Espectroscopía de Resonancia Magnética/métodos , Ácido Aspártico/análogos & derivados , Ácido Aspártico/análisis , Agua Corporal/química , Colina/análisis , Creatina/análisis , Análisis de Fourier , Humanos , Procesamiento de Imagen Asistido por Computador/métodos , Fantasmas de Imagen , Procesamiento de Señales Asistido por Computador , Factores de TiempoRESUMEN
We conducted a 6-week open-label trial of riluzole (50 mg twice a day) in eight subjects with Huntington's disease. Subjects were evaluated before riluzole treatment, on treatment, and off treatment with the chorea, dystonia, and total functional capacity (TFC) scores from the Unified Huntington's Disease Rating Scale and magnetic resonance spectroscopy measurements of occipital cortex and basal ganglia lactate levels. Adverse events and safety blood and urine tests were assessed throughout the study. All subjects completed the study and riluzole was well tolerated. The age was 45+/-10.2 years (mean +/- standard deviation) and the disease duration was 6.1+/-4.1 years. The chorea rating score improved by 35% on treatment (p = 0.013) and worsened after discontinuation of treatment (p = 0.026). There were no significant treatment effects on the dystonia or TFC scores. The baseline occipital and basal ganglia lactate levels were elevated in all subjects; there was a trend toward lower lactate/creatine ratios during riluzole treatment in the basal ganglia spectra but not in occipital cortex spectra. Additional clinical studies of riluzole for both symptomatic and neuroprotective benefit in Huntington's disease are warranted.
Asunto(s)
Antagonistas de Aminoácidos Excitadores/uso terapéutico , Enfermedad de Huntington/tratamiento farmacológico , Fármacos Neuroprotectores/uso terapéutico , Riluzol/uso terapéutico , Adulto , Ganglios Basales/efectos de los fármacos , Ganglios Basales/metabolismo , Corea/tratamiento farmacológico , Antagonistas de Aminoácidos Excitadores/efectos adversos , Femenino , Humanos , Enfermedad de Huntington/metabolismo , Ácido Láctico/metabolismo , Espectroscopía de Resonancia Magnética , Masculino , Persona de Mediana Edad , Fármacos Neuroprotectores/efectos adversos , Lóbulo Occipital/efectos de los fármacos , Lóbulo Occipital/metabolismo , Proyectos Piloto , Riluzol/efectos adversos , Índice de Severidad de la Enfermedad , Método Simple Ciego , Resultado del TratamientoRESUMEN
The number of physiologic and metabolic phenomena amenable to analysis using magnetic resonance (MR) techniques is increasing every year. MR techniques can now evaluate tissue parameters relevant to TCA cyclemetabolism, anerobic glycolysis, ATP levels, blood-brain barrier permeability, macrophage infiltration, cytotoxic edema, spreading depression, cerebral blood flow and volume, and neurotransmitter function. The paramagnetic nature of certain oxidation states of iron leads to the ability to map out brain function using deoxyhemoglobin as an endogenous contrast agent, and also allows for mapping of local tissue iron concentrations. In addition to these metabolic parameters, the number of ways to generate anatomic contrast using MR is also expanding; and in addition to conventional anatomic scans, mapping of axonal fiber tracts can also be performed using the anisotropy of water diffusion. A strategy for integration of these multifarious parameters in a comprehensive neurofunctional exam in neurodegenerative illness is outlined in this paper. The goals of the integrated exam, as applied to a given neurodegenerative illness, can be subdivided into three categories: etiology, natural history, and therapeutic end points. The consequences of oxidative stress and/or mitochondrial dysfunction are explored in the context of the various parameters that can be measured using the integrated MR exam.